![](https://endpts.com/wp-content/uploads/2023/05/Angelini-Pharma-CEO-Jacopo-Andreose-1.jpg)
Jacopo Andreose, Angelini Pharma CEO
Italy's Angelini Pharma teams up with JCR on blood-brain barrier deal
Angelini Pharma plans to pay Japanese pharma JCR Pharmaceuticals more than $500 million as part of a research collaboration that focuses on the blood-brain barrier …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.